CVS Group PLC, a leading provider of integrated veterinary services in the UK, has disclosed the purchase of Ordinary Shares by key individuals within the company. David Wilton, the Non-Executive Chair, acquired 2,500 Ordinary Shares, increasing his total interest in the company to 9,000 shares. Deborah Kemp, a Non-Executive Director, purchased 2,440 Ordinary Shares, bringing her total interest to 10,453 shares. Additionally, Robin Alfonso's wife acquired 1,004 Ordinary Shares, resulting in Mr. Alfonso's total interest, including his wife's holdings, to 24,377 Ordinary Shares.
These transactions were made in accordance with the UK Market Abuse Regulation (UK MAR) and were notified to the company. The purchases were on-market transactions and were conducted on the London Stock Exchange - AIM (XLON). The prices per share ranged from 1,019.00 to 1,052.00 pence.
The company's CEO, Richard Fairman, and Company Secretary, Scott Morrison, can be contacted for further information. Peel Hunt LLP and Berenberg are serving as the Nominated Adviser & Broker and Joint Broker, respectively, for CVS Group PLC. Camarco is handling financial PR for the company.
This announcement provides insight into the recent share purchases by key individuals within CVS Group PLC, offering transparency and compliance with regulatory requirements.